Update regarding the 2022-2023 Mississippi Medicaid RSV season: Mississippi Medicaid coverage of palivizumab (Synagis®) for the 2022-2023 RSV season will end on March 31, 2023.
Update regarding the 2022-2023 Mississippi Medicaid RSV season: Mississippi Medicaid coverage of palivizumab (Synagis®) for the 2022-2023 RSV season will end on March 31, 2023.
![]() |
The Mississippi Division of Medicaid responsibly provides access to quality health coverage for vulnerable Mississippians. |
![]() |